Pandemic to delay cancer advances by nearly 18 months, researchers fear 30 Nov 2020 A survey of more than 200 researchers details impact of the pandemic. The scientists estimate their own research has been put back by six months through loss of access to labs, facilities, trials and samples. But they feel science has now adapted to COVID-19 – and researchers believe donations and Government support could accelerate recovery. Find out more Show/Hide
Time for family, friends and travel most valued by patients living with cancer 09 Mar 2020 Spending time with family is what cancer patients would most value if new treatments allowed them to live for longer, a new YouGov poll reveals. Find out more Show/Hide
Statement in response to NICE approval of dabrafenib for the treatment of certain cases of advanced melanoma 17 Sep 2014 Professor Paul Workman comments on final draft guidance from NICE recommending dabrafenib for the treatment of advanced melanoma which tests positive for the BRAF V600 mutation. Find out more Show/Hide